Welcome and Keynote Session: The future of pharmacoepidemiology, powered by technology

We are entering a transformational stage of new data sources, data types and analysis ‎methods. Most patients and the public now carry powerful computers in their pockets or ‎bags, or on their wrists. The power (and some limitations) of AI have become visible to us all ‎through ChatGPT and other large language models. This technology offers important ‎emerging opportunities for our community.‎

This session will educate and inspire conference delegates about how current technology, ‎already within reach, can be used to advance pharmacoepidemiology. The plenary session ‎will start with a broad overview of how technology might power pharmacoepidemiology, ‎before moving onto the specific topics about the collection of person-generated health ‎data (PGHD) via smartphones and wearables, and the use of artificial intelligence to analyse ‎big, multimodal data. Each of these topics will include a high-profile external speaker to ‎showcase what is happening beyond our community and a speaker from the ICPE ‎community focussing on past, current, and future applications in pharmacoepidemiology. ‎This will ensure delegates understand how external developments might be applied to the ‎work we do in our field.‎

Chairpersons
Nancy Dreyer, Dreyer Strategies ‎
Daniel Caños, Office of Clinical Evidence and Analysis, Office of Product Evaluation and ‎Quality, Center for Devices and Radiological Health, FDA‎

Speakers

Person-generated health data
ICPE speaker: Will Dixon, University of Manchester‎
Invited expert: Paul Strijbos, Product Development Neuroscience, Roche

Artificial Intelligence
Invited expert: Martin Seneviratne, Phare Health
ICPE speaker: Kathryn Rough, Center for Advanced Evidence Generation, IQVIA